CLEVELAND, April 1, 2011 /PRNewswire/ -- RSB Spine, LLC, a medical device company focused on developing unique modular fusion products for surgical treatment of degenerative disc disease, today announced a 145% sales increase for the first quarter of 2011 versus first-quarter 2010, marking its sixth consecutive quarter of revenue growth.
"We are pleased with the momentum achieved by this product," said Mike O'Neill, CEO of Paradigm BioDevices, "and, as a result, are intensifying efforts to expand and upgrade our distribution network."
RSB Spine is a privately held medical device company. News releases and other information on the company are available on the Internet at: http://www.rsbspine.com.
Paradigm BioDevices, Inc. is a privately held Boston-based medical device distributor. News releases and other information on the company are available at www.paradigmbiodevices.com.